A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide

Glioblastoma is the most malignant brain tumor, exhibiting remarkable resistance to treatment. Here we investigated the oncogenic potential of HOXA9 in gliomagenesis, the molecular and cellular mechanisms by which HOXA9 renders glioblastoma more aggressive, and how HOXA9 affects response to chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pojo, Marta, Gonçalves, Céline S., Xavier-Magalhães, Ana, Oliveira, Ana Isabel, Gonçalves, Tiago, Correia, Sara, Rodrigues, Ana J., Costa, Sandra, Pinto, Luísa, Pinto, Afonso A., Lopes, José M., Reis, Rui M., Rocha, Miguel, Sousa, Nuno, Costa, Bruno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480707/
https://www.ncbi.nlm.nih.gov/pubmed/25762636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480707/
https://www.ncbi.nlm.nih.gov/pubmed/25762636

Ejemplares similares